1. Home
  2. GLMD vs FBGL Comparison

GLMD vs FBGL Comparison

Compare GLMD & FBGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • FBGL
  • Stock Information
  • Founded
  • GLMD 2000
  • FBGL 1996
  • Country
  • GLMD Israel
  • FBGL Singapore
  • Employees
  • GLMD N/A
  • FBGL N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • FBGL Miscellaneous manufacturing industries
  • Sector
  • GLMD Health Care
  • FBGL Consumer Discretionary
  • Exchange
  • GLMD Nasdaq
  • FBGL Nasdaq
  • Market Cap
  • GLMD 7.9M
  • FBGL 8.5M
  • IPO Year
  • GLMD 2014
  • FBGL 2025
  • Fundamental
  • Price
  • GLMD $1.49
  • FBGL $0.52
  • Analyst Decision
  • GLMD Hold
  • FBGL
  • Analyst Count
  • GLMD 1
  • FBGL 0
  • Target Price
  • GLMD N/A
  • FBGL N/A
  • AVG Volume (30 Days)
  • GLMD 164.0K
  • FBGL 38.7K
  • Earning Date
  • GLMD 09-02-2025
  • FBGL 01-01-0001
  • Dividend Yield
  • GLMD N/A
  • FBGL N/A
  • EPS Growth
  • GLMD N/A
  • FBGL N/A
  • EPS
  • GLMD N/A
  • FBGL N/A
  • Revenue
  • GLMD N/A
  • FBGL $10,146,582.00
  • Revenue This Year
  • GLMD N/A
  • FBGL N/A
  • Revenue Next Year
  • GLMD N/A
  • FBGL N/A
  • P/E Ratio
  • GLMD N/A
  • FBGL N/A
  • Revenue Growth
  • GLMD N/A
  • FBGL N/A
  • 52 Week Low
  • GLMD $1.15
  • FBGL $0.44
  • 52 Week High
  • GLMD $23.80
  • FBGL $5.45
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 44.36
  • FBGL N/A
  • Support Level
  • GLMD $1.35
  • FBGL N/A
  • Resistance Level
  • GLMD $1.59
  • FBGL N/A
  • Average True Range (ATR)
  • GLMD 0.11
  • FBGL 0.00
  • MACD
  • GLMD 0.00
  • FBGL 0.00
  • Stochastic Oscillator
  • GLMD 44.56
  • FBGL 0.00

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and Sales of construction materials.

Share on Social Networks: